Vireo Growth (VREOF) Other Operating Expenses (2020 - 2026)
Vireo Growth's (VREOF) quarterly Other Operating Expenses came in at -$10.2 million in Q1 2026, down 950.0% year-on-year from $1.2 million in Q1 2025, and down 34.85% quarter-over-quarter from -$7.6 million in Q4 2025.
Vireo Growth (VREOF) Other Operating Expenses (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Other Operating Expenses across 7 years of filings, most recently posting -$10.2 million for Q1 2026.
- Other Operating Expenses for Q1 2026 came in at -$10.2 million, down 950.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$15.1 million (down 331.3% YoY), and the FY2025 annual result was -$3.6 million, down 290.12% from the prior year.
- Other Operating Expenses came in at -$10.2 million for Q1 2026 at Vireo Growth, down from -$7.6 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $6.7 million in Q4 2024 to a low of -$10.2 million in Q1 2026.
- The 5-year median for Other Operating Expenses is -$571303.0 (2023), against an average of -$759060.3.
- Across the five-year window, Other Operating Expenses jumped 1273.64% in 2024 and tumbled 950.0% in 2026, its largest moves.
- Vireo Growth's Other Operating Expenses stood at -$1.3 million in 2022, then soared by 55.93% to -$571303.0 in 2023, then surged by 1273.64% to $6.7 million in 2024, then plunged by 212.81% to -$7.6 million in 2025, then plunged by 34.85% to -$10.2 million in 2026.
- The last three Other Operating Expenses figures came in at -$10.2 million (Q1 2026), -$7.6 million (Q4 2025), and $588353.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.20 Mn |
| Dec 31, 2025 | -7.56 Mn |
| Sep 30, 2025 | 588,353.00 |
| Jun 30, 2025 | 2.12 Mn |
| Mar 31, 2025 | 1.20 Mn |
| Dec 31, 2024 | 6.71 Mn |
| Sep 30, 2024 | -88,641.00 |
| Jun 30, 2024 | -1.31 Mn |
| Mar 31, 2024 | -960,759.00 |
| Dec 31, 2023 | -571,303.00 |
| Sep 30, 2023 | -923,329.00 |
| Jun 30, 2023 | 601,998.00 |
| Mar 31, 2023 | 226,654.00 |
| Dec 31, 2022 | -1.30 Mn |
| Sep 30, 2022 | -775,047.00 |
| Jun 30, 2022 | -828,401.00 |
| Mar 31, 2022 | 168,359.00 |
| Dec 31, 2021 | 6.47 Mn |
| Mar 31, 2021 | 437,107.00 |
| Dec 31, 2020 | 3.37 Mn |